A miRNA-135a/b binding polymorphism, the SNP rs2240688A > C in the 3′-untranslated region of CD133, is considered to be a functional biomarker for the prediction of risk and prognosis in lung cancer. The gene discussed is PROM1; the disease is lung carcinoma.